MedBot Records Stable Share Base with No Issuance or Buy-Backs in May 2026

Bulletin Express06-03

Shanghai MicroPort MedBot (Group) Co., Ltd. (MedBot, HKEX: 02252) has filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month.

Total authorised share capital stayed at RMB 1.03 billion, comprising 1.03 billion H shares and 609,745 domestic shares, each with a par value of RMB 1. The issued share count was also steady at 1.03 billion H shares and 609,745 domestic shares. MedBot held no treasury shares at month-end and reported zero share issuances, cancellations, or repurchases in May.

The company’s 2022 Share Option Scheme shows no outstanding options and no exercises during the month. Up to 95.20 million H shares remain available for potential future grants, but none were issued in May. No warrants, convertible securities, or other equity-linked instruments were outstanding or exercised.

MedBot affirmed compliance with Hong Kong Stock Exchange public-float requirements, maintaining at least 25% of H shares in public hands. The monthly return was submitted on 3 June 2026 by Company Secretary Yeung Siu Lam.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment